Enable Biosciences
South San Francisco
About Enable Biosciences
Enable Biosciences is a biotech company making ultrasensitive tests for hiv, type 1 diabetes, and many other diseases. They develop ultrasensitive immunoassays that permit early detection and treatment of autoimmune and infectious diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $4.2M
- Last round: Undisclosed (Apr 2024)
- Website: enablebiosciences.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Life Science
Social Profiles
Canonical: https://fsome.com/organization/enable-biosciences-65868 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.